
HTG Molecular Diagnostics HTGM
Geschäftsbericht 2022
hinzugefügt 30.03.2023
HTG Molecular Diagnostics EBITDA per Share 2011-2026 | HTGM
EBITDA per Share Jährlich HTG Molecular Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -22.8 | -29.6 | -3.94 | -6.78 | -8.01 | -23.3 | -48.2 | -60.5 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -3.94 | -60.5 | -25.4 |
EBITDA per Share Vierteljährlich HTG Molecular Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -0.38 | -0.5 | -0.76 | - | -0.54 | -0.58 | -0.73 | - | -1.01 | -1.05 | -1.17 | - | -0.14 | -0.15 | -0.18 | - | -0.16 | -0.13 | -0.2 | - | -0.41 | -0.53 | -0.64 | - | -0.81 | -0.85 | -0.92 | - | -0.68 | -1.15 | -11.5 | - | -28.7 | -34.6 | -27.3 | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.13 | -34.6 | -4.29 |
EBITDA per Share anderer Aktien in der Diagnostik & Forschung
| Name | EBITDA per Share | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Burning Rock Biotech Limited
BNR
|
-4.62 | $ 17.1 | 0.56 % | $ 181 M | ||
|
CareDx, Inc
CDNA
|
-0.3 | $ 21.5 | 3.32 % | $ 1.15 B | ||
|
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.15 | - | -61.36 % | $ 2.46 M | ||
|
Agilent Technologies
A
|
5.49 | $ 114.52 | -0.86 % | $ 34.8 B | ||
|
Co-Diagnostics
CODX
|
-36.9 | $ 1.55 | - | $ 2.06 M | ||
|
Castle Biosciences
CSTL
|
0.89 | $ 24.81 | 1.31 % | $ 689 M | ||
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M | ||
|
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | ||
|
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | ||
|
Fulgent Genetics
FLGT
|
-1.62 | $ 14.13 | -6.98 % | $ 427 M | ||
|
ICON Public Limited Company
ICLR
|
19.2 | $ 112.85 | -4.63 % | $ 9.31 B | ||
|
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M | ||
|
Check-Cap Ltd.
CHEK
|
-4.41 | - | - | $ 9.42 M | ||
|
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | ||
|
Illumina
ILMN
|
-3.01 | $ 135.78 | 7.13 % | $ 21.6 B | ||
|
Lantheus Holdings
LNTH
|
5.64 | $ 85.5 | 1.04 % | $ 5.77 B | ||
|
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | ||
|
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | ||
|
Myriad Genetics
MYGN
|
-3.6 | $ 4.8 | 1.05 % | $ 444 M | ||
|
NeoGenomics
NEO
|
-0.62 | $ 9.44 | 1.94 % | $ 1.21 B | ||
|
Medpace Holdings
MEDP
|
19.5 | $ 417.54 | -0.27 % | $ 12 B | ||
|
National Research Corporation
NRC
|
1.35 | $ 17.41 | 5.77 % | $ 390 M | ||
|
Charles River Laboratories International
CRL
|
8.64 | $ 165.78 | -0.71 % | $ 8.22 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | ||
|
Koninklijke Philips N.V.
PHG
|
0.61 | $ 26.16 | -0.87 % | $ 20 B | ||
|
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | ||
|
Guardant Health
GH
|
-3.17 | $ 87.6 | 0.6 % | $ 11 B | ||
|
Personalis
PSNL
|
-0.97 | $ 5.78 | 4.71 % | $ 342 M | ||
|
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | ||
|
Interpace Biosciences
IDXG
|
1.02 | $ 2.12 | 7.07 % | $ 9.38 M | ||
|
Senseonics Holdings
SENS
|
-1.6 | $ 5.1 | -22.84 % | $ 213 M | ||
|
Soleno Therapeutics
SLNO
|
0.22 | $ 52.87 | 0.09 % | $ 2.69 B | ||
|
Thermo Fisher Scientific
TMO
|
23.3 | $ 469.21 | -2.04 % | $ 177 B | ||
|
QIAGEN N.V.
QGEN
|
3.04 | - | - | $ 10.6 B | ||
|
Twist Bioscience Corporation
TWST
|
-1.86 | $ 60.4 | 3.34 % | $ 3.61 B | ||
|
Biomerica
BMRA
|
-2.2 | $ 2.19 | 0.46 % | $ 5.03 M | ||
|
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 255.84 | -0.37 % | $ 21.3 B | ||
|
Celcuity
CELC
|
-3.68 | $ 125.65 | 3.54 % | $ 5.88 B | ||
|
Natera
NTRA
|
-5.33 | $ 207.28 | 0.54 % | $ 20.4 B | ||
|
Neogen Corporation
NEOG
|
-4.34 | $ 9.53 | 1.38 % | $ 2.07 B | ||
|
Invitae Corporation
NVTA
|
0.2 | - | - | $ 21.2 M | ||
|
Waters Corporation
WAT
|
6.02 | $ 307.12 | -0.68 % | $ 18.3 B | ||
|
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 192.67 | -0.79 % | $ 21.4 B |